Source: Urologic Oncology. Unidade: FM
Subjects: NEOPLASIAS DA BEXIGA, INFLAMAÇÃO, CITOCINAS, VACINAS VIRAIS, RATOS
ABNT
ANDRADE, Priscila M. et al. The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer. Urologic Oncology, v. 28, n. 5, p. 520-525, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.urolonc.2008.12.017. Acesso em: 04 set. 2024.APA
Andrade, P. M., Chade, D. C., Borra, R. C., Nascimento, I. P., Villanova, F. E., Leite, L. C. C., et al. (2010). The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer. Urologic Oncology, 28( 5), 520-525. doi:10.1016/j.urolonc.2008.12.017NLM
Andrade PM, Chade DC, Borra RC, Nascimento IP, Villanova FE, Leite LCC, Andrade E, Srougi M. The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer [Internet]. Urologic Oncology. 2010 ; 28( 5): 520-525.[citado 2024 set. 04 ] Available from: https://doi.org/10.1016/j.urolonc.2008.12.017Vancouver
Andrade PM, Chade DC, Borra RC, Nascimento IP, Villanova FE, Leite LCC, Andrade E, Srougi M. The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer [Internet]. Urologic Oncology. 2010 ; 28( 5): 520-525.[citado 2024 set. 04 ] Available from: https://doi.org/10.1016/j.urolonc.2008.12.017